Philip Gordts | Extracellular matrix as a therapeutic entry point for hepcidin modulation
CIHD Seminar Series: Philip Gordts, Ph.D. (University of Utah) presents "Extracellular matrix as a therapeutic entry point for hepcidin modulation"
CCEH
Bringing together Centers of Excellence to advance benign hematology research
